Marion McCourt
Corporate Officer/Principal bij REGENERON PHARMACEUTICALS, INC.
Vermogen: 13 M $ op 29-02-2024
Profiel
Marion McCourt is on the board of Girls On The Run International and Executive Vice President-Commercial at Regeneron Pharmaceuticals, Inc.
Ms. McCourt previously occupied the position of President & Chief Operating Officer at Sio Gene Therapies, Inc., Vice President-US Commercial Operations at Amgen, Inc., Chief Operating Officer-United States Region at AstraZeneca PLC President & Chief Executive Officer at AstraZeneca Canada, Inc. and Vice President-Managed Markets & Government at AstraZeneca Pharmaceuticals LP (both are subsidiaries of AstraZeneca PLC) and Chief Operating Officer for Medivation LLC (California).
She received an undergraduate degree from Lafayette College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-03-2024 | 13 589 ( 0.01% ) | 13 M $ | 29-02-2024 |
Actieve functies van Marion McCourt
Bedrijven | Functie | Begin |
---|---|---|
REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12-02-2018 |
Girls On The Run International
Girls On The Run International Miscellaneous Commercial ServicesCommercial Services Girls On The Run International is a non-profit organization based in Charlotte, NC that offers a physical activity-based positive youth development program for girls in 3rd-8th grade. The program's evidence-based curriculum focuses on developing competence, confidence, connection, character, caring, and contribution in young girls through lessons that incorporate running and other physical activities. The program has served over 2 million girls since its inception in 1996 and has councils in all 50 states and the District of Columbia. An independent study found that 97% of participants learned critical life skills that they continue to use at home, at school, and with their friends. Girls On The Run also offers Heart & Sole, an after-school program for girls in 6th-8th grade. | Director/Board Member | - |
Eerdere bekende functies van Marion McCourt
Bedrijven | Functie | Einde |
---|---|---|
SCYNEXIS, INC. | Director/Board Member | 18-09-2018 |
CYTOMX THERAPEUTICS, INC. | Director/Board Member | 13-06-2018 |
SIO GENE THERAPIES INC. | President | 12-02-2018 |
MEDIVATION INC | Chief Operating Officer | 01-09-2016 |
AMGEN INC. | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Marion McCourt
Lafayette College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
AMGEN INC. | Health Technology |
REGENERON PHARMACEUTICALS, INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
SCYNEXIS, INC. | Health Technology |
CYTOMX THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Girls On The Run International
Girls On The Run International Miscellaneous Commercial ServicesCommercial Services Girls On The Run International is a non-profit organization based in Charlotte, NC that offers a physical activity-based positive youth development program for girls in 3rd-8th grade. The program's evidence-based curriculum focuses on developing competence, confidence, connection, character, caring, and contribution in young girls through lessons that incorporate running and other physical activities. The program has served over 2 million girls since its inception in 1996 and has councils in all 50 states and the District of Columbia. An independent study found that 97% of participants learned critical life skills that they continue to use at home, at school, and with their friends. Girls On The Run also offers Heart & Sole, an after-school program for girls in 6th-8th grade. | Commercial Services |